Core Viewpoint - Quanex Building Products Corporation is actively engaging with institutional investors at the upcoming Wells Fargo Industrials & Materials Conference, indicating a focus on investor relations and potential growth opportunities [1]. Company Overview - Quanex is a global manufacturer with diverse capabilities across various end markets, including window, door, solar, refrigeration, custom mixing, building access, and cabinetry [2]. - The company collaborates with leading OEMs to provide innovative solutions, showcasing its commitment to partnerships and technological advancements [2]. - Looking forward, Quanex aims to leverage its material science expertise and process engineering to expand into adjacent markets, indicating a strategic growth plan [2].

Core Viewpoint - Precision Optics Corporation will participate in the Lytham Partners Spring 2025 Investor Conference, hosting a webcast presentation and one-on-one meetings with investors on May 29, 2025 [1][2][3]. Company Overview - Founded in 1982, Precision Optics is a vertically integrated optics company focused on advanced optical instruments for the medical and defense/aerospace industries [4]. - The company leverages proprietary micro-optics, 3D imaging, and digital imaging technologies to provide services from product concept to mass manufacture [4]. - Precision Optics supports next-generation medical device companies by providing enhanced imaging systems for minimally invasive surgery and 3D endoscopy systems [4]. - The company has a long history of supplying optical products, including complex endocouplers and specialized endoscopes, to top-tier medical device companies [4]. - In the defense/aerospace sector, Precision Optics applies its technical proficiency in micro-optics to meet high-quality standards while optimizing size, weight, and power [4].

FARGO, N.D., May 27, 2025 (GLOBE NEWSWIRE) -- NI Holdings, Inc. (the “Company”, NASDAQ: NODK) today announced several strategic leadership appointments to support the company’s long-term growth and execution of its core business strategies. “We are excited to announce multiple executive leadership appointments,” said Seth Daggett, President and Chief Executive Officer of NI Holdings. “These individuals bring deep operational knowledge, extensive industry experience and strategic insight to our executive tea ...

CHANDLER, Ariz., May 27, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the TD Cowen 53rd Annual Global Technology, Media, and Communications Conference on Wednesday, May 28, 2025 at 10:50 a.m. (Eastern Time). Presenting for the Company will be Mr. Richard Simoncic, Chief Operating Officer, and Mr. Eric Bjornholt, Senior Vice President and Chief Financi ...

HOUSTON, May 27, 2025 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company” or “KYN”) announced today the appointments of Holli C. Ladhani and Michael N. Mears as independent directors of the Company, effective immediately. Following the retirements of Anne K. Costin and Albert L. Richey earlier this year, the appointments of Ms. Ladhani and Mr. Mears return the Company’s Board to eight members, seven of whom are independent. Holli C. Ladhani is an experienced executive and boar ...

NORTH PLAINS, Ore., May 27, 2025 (GLOBE NEWSWIRE) -- Jewett-Cameron Trading Company Ltd. (“Jewett-Cameron”) (Nasdaq: JCTC), a company committed to innovative products that enrich outdoor spaces, today announced that it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2025 Investor Conference, taking place virtually on Thursday, May 29, 2025. Company Webcast The webcast presentation will take place at 12:30 p.m. ET on Thursday, May 29, 2025. ...

Core Viewpoint - China Natural Resources, Inc. has announced an eight-to-one share combination to increase its per share trading price and meet Nasdaq listing requirements [1][3]. Group 1: Share Combination Details - The board of directors has approved an eight-to-one share combination of issued and outstanding common shares, effective June 12, 2025 [1]. - Every eight issued and outstanding common shares will automatically convert into one common share, with fractional shares rounded up to the next whole share [2]. - The share combination will not affect the total number of authorized common shares, and all outstanding options and warrants will be adjusted proportionately [3]. Group 2: Company Operations and Strategy - China Natural Resources operates in exploration and mining, focusing on acquiring and exploiting mining rights in Inner Mongolia, including lead, silver, and other nonferrous metals [4]. - The company is in the process of acquiring Williams Minerals, which operates a lithium mine in Zimbabwe, for a maximum consideration of US$1.75 billion [4].

Core Insights - AnaptysBio, Inc. is hosting an investor call and live webcast to discuss updated data from the Phase 2b RENOIR clinical trial of rosnilimab for rheumatoid arthritis on June 3, 2025 [1] - The event will feature key management members and clinical trial investigators, highlighting the company's commitment to transparency and investor engagement [2] Company Overview - AnaptysBio is a clinical-stage biotechnology company focused on innovative immunology therapeutics for autoimmune and inflammatory diseases [4] - The lead program, rosnilimab, is currently in a Phase 2b trial for rheumatoid arthritis and a Phase 2 trial for ulcerative colitis [4] - The pipeline includes ANB033, a CD122 antagonist, and ANB101, a BDCA2 modulator, both in Phase 1 trials [4] - The company has collaborations with GSK for multiple therapeutic antibodies, including a PD-1 antagonist and a TIM-3 antagonist [4] Upcoming Events - AnaptysBio's executive leadership will participate in several investor conferences following the data release, including the Jefferies Global Healthcare Conference and the Goldman Sachs 46th Annual Global Healthcare Conference [3] - Live webcasts of the data release and subsequent presentations will be available on the company's investor website, with replays accessible for at least 30 days [3]

BURLINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments for neuropsychiatric disorders, today announced an upcoming presentation at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting. Presentation details: Title: Pharmacokinetic/Pharmacodynamic Analysis of the BNC210 Attune Phase 2b Dataset Enables Dose Selection for Planned Phase 3 PTSD St ...

Company Overview - Gevo, Inc. is a leader in sustainable aviation fuel and renewable chemicals, focusing on cost-effective, drop-in fuels that enhance energy security and support rural economic growth [1][3] - The company operates one of the largest dairy-based renewable natural gas facilities in the U.S. and an ethanol plant with a carbon capture and sequestration facility [3] Leadership Appointment - James J. Barber, Ph.D., has been appointed to Gevo's Board of Directors, bringing extensive executive leadership and board experience in various sectors including fuels and chemicals [1][2] - Dr. Barber holds a Ph.D. in Organic Chemistry from MIT and has received the American Chemical Society's Henry F. Whalen, Jr. Award for Business Development [2] Strategic Importance - The CEO of Gevo, Dr. Patrick R. Gruber, emphasized that Dr. Barber's technical expertise and strategic insight will be crucial for the company's growth [3] - Gevo's business model aims to revitalize rural communities by developing and operating production facilities that create jobs [3]